Abstract:BACKGROUND: Placenta accreta spectrum disorders are associated with severe maternal morbidity and mortality. Placenta accreta spectrum disorders involve excessive adherence of the placenta preventing separation at birth. Traditionally, this condition has been attributed to excessive trophoblast invasion; however, an alternative view is a fundamental defect in decidual biology.OBJECTIVE: This study aimed to gain insights into the understanding of placenta accreta spectrum disorder by using single-cell and spatially resolved transcriptomics to characterize cellular heterogeneity at the maternal-fetal interface in placenta accreta spectrum disorders.STUDY DESIGN: To assess cellular heterogeneity and the function of cell types, single-cell RNA sequencing and spatially resolved transcriptomics were used. A total of 12 placentas were included, 6 placentas with placenta accreta spectrum disorder and 6 controls. For each placenta with placenta accreta spectrum disorder, multiple biopsies were taken at the following sites: placenta accreta spectrum adherent and nonadherent sites in the same placenta. Of note, 2 platforms were used to generate libraries: the 10× Chromium and NanoString GeoMX Digital Spatial Profiler for single-cell and spatially resolved transcriptomes, respectively. Differential gene expression analysis was performed using a suite of bioinformatic tools (Seurat and GeoMxTools R packages). Correction for multiple testing was performed using Clipper. In situ hybridization was performed with RNAscope, and immunohistochemistry was used to assess protein expression.RESULTS: In creating a placenta accreta cell atlas, there were dramatic difference in the transcriptional profile by site of biopsy between placenta accreta spectrum and controls. Most of the differences were noted at the site of adherence; however, differences existed within the placenta between the adherent and nonadherent site of the same placenta in placenta accreta. Among all cell types, the endothelial-stromal populations exhibited the greatest difference in gene expression, driven by changes in collagen genes, namely collagen type III alpha 1 chain (COL3A1), growth factors, epidermal growth factor-like protein 6 (EGFL6), and hepatocyte growth factor (HGF), and angiogenesis-related genes, namely delta-like noncanonical Notch ligand 1 (DLK1) and platelet endothelial cell adhesion molecule-1 (PECAM1). Intraplacental tropism (adherent versus non-adherent sites in the same placenta) was driven by differences in endothelial-stromal cells with notable differences in bone morphogenic protein 5 (BMP5) and osteopontin (SPP1) in the adherent vs nonadherent site of placenta accreta spectrum.CONCLUSION: Placenta accreta spectrum disorders were characterized at single-cell resolution to gain insight into the pathophysiology of the disease. An atlas of the placenta at single cell resolution in accreta allows for understanding in the biology of the intimate maternal and fetal interaction. The contributions of stromal and endothelial cells were demonstrated through alterations in the extracellular matrix, growth factors, and angiogenesis. Transcriptional and protein changes in the stroma of placenta accreta spectrum shift the etiologic explanation away from "invasive trophoblast" to "loss of boundary limits" in the decidua. Gene targets identified in this study may be used to refine diagnostic assays in early pregnancy, track disease progression over time, and inform therapeutic discoveries.

Scar matrix drives Piezo1 mediated stromal inflammation leading to placenta accreta spectrum

Uterine Scarring Leads to Adverse Pregnant Consequences by Impairing the Endometrium Response to Steroids

Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders

Mapping the 3D Remodeling of the Extracellular Matrix in Human Hypertrophic Scar by Multi-Parametric Multiphoton Imaging Using Endogenous Contrast

Spatial proteomics and transcriptomics of the maternal-fetal interface in placenta accreta spectrum

Uterine damage induces placenta accreta and immune imbalance at the maternal-fetal interface in the mouse

Spatial proteomics and transcriptomics of placenta accreta spectrum

Placenta accreta spectrum disorder at single-cell resolution: a loss of boundary limits in the decidua and endothelium

Microcellular approach for the pathogenesis of placenta accreta spectrum inflammatory versus apoptotic pathways; a thorough look on Treg, dNK and VEGF

Mechanobiological regulation of placental trophoblast fusion and function through extracellular matrix rigidity

Abnormal Placental Development Induced by Repeated Cesarean Sections: Investigating an Animal Model of Placenta Accreta Spectrum Disorders

The Underlying Molecular Mechanisms of the Placenta Accreta Spectrum: A Narrative Review

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Upregulated LncZBTB39 in Pre-Eclampsia and Its Effects on Trophoblast Invasion and Migration Via Antagonizing the Inhibition of Mir-210 on THSD7A Expression.

Biomechanical Modeling of Cesarean Section Scars and Scar Defects

Uterine Cesarean Scar Tissue-An Immunohistochemical Study

Endothelial progenitor cells control remodeling of uterine spiral arteries for the establishment of utero-placental circulation

What We Know about Placenta Accreta Spectrum (PAS)

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Injury triggers fascia fibroblast collective cell migration to drive scar formation through N-cadherin

Umbilical Cord-Derived Mesenchymal Stem Cells on Scaffolds Facilitate Collagen Degradation Via Upregulation of MMP-9 in Rat Uterine Scars